Mechanisms of HIV infection in resting CD4+ t cells stimulated by endothelial cells
Active Project Grant Awarded
- Award ID
- R15AI195005
- Recipient
-
Calvin University UEI NNLQK7LNGL93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $450,764
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 10% complete
- Place of performance
- Grand Rapids, MI 49546, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded Calvin University $450,764 on July 13, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate mechanisms of HIV infection in resting CD4+ T cells stimulated by endothelial cells.
The research examines how endothelial cells in lymphoid tissues promote both productive and latent HIV infection in resting CD4+ T cells, with the goal of elucidating factors that contribute to latent reservoir formation—a key barrier to HIV cure. The study pursues three specific aims: investigating the roles of integrin on HIV infection of CD4+ T cells; examining the role of BCL-3, BCL-6, and SAMHD1 on HIV infection in endothelial cell-stimulated resting CD4+ T cells; and identifying T cell subtypes and signature molecules correlated with HIV infection in this context. Methodological approaches include blocking and chimeric antibodies to test integrin effects, intracellular staining to determine expression correlations, and related molecular and cellular techniques.
Performance occurs at Calvin University in Grand Rapids, Michigan, with a period of performance from July 13, 2026, through June 30, 2029. The Allergy and Infectious Diseases Research program funds research to establish, expand, and improve biomedical research and research training in infectious diseases and related areas, supporting innovative research addressing urgent and emerging health challenges.
Description
- Abstract
- In most patients with HIV-1 infection, antiretroviral therapy (art) successfully suppresses viral loads and restores CD4+ t cell numbers. However, lifelong therapy is required to maintain viral suppression, primarily due to a major latent reservoir in resting CD4+ t cells. The latent reservoir poses a great barrier to HIV cure and ensures viral persistence in patients. Knowledge about how such a latent reservoir is formed is limited. A more complete understanding of the mechanisms contributing to the establishment of the reservoir will impact the strategies in battling viral persistence. Microenvironment of the lymphoid tissue and cell-cell interactions in vivo played important roles in latency formation in resting CD4+ t cells. IT was found that endothelial cells (ECS), which physiologically interact readily with t cells in the lymphoid tissues in vivo, promote both productive and latent HIV infection in resting CD4+ t cells and may play a significant role in latency formation in these cells in vivo. Having established the importance of ECS in HIV infection and latency formation, this study is to elucidate further the mechanisms involved in EC stimulation of t cells. The specific aims of the proposal are: 1. To investigate the roles of integrin on HIV infection of CD4+ t cells. 2. To examine the role of BCL-3, BCL-6, and SAMHD1 on HIV infection in EC-stimulated resting CD4+ t cells. 3. To identify t cell subtypes and signature molecules correlated with HIV infection in EC-stimulated CD4+ t cells. To achieve specific aim 1, blocking antibodies will be used to block integrins during EC stimulation of t cells. Chimeric antibodies will be used to stimulate integrins on t cells to see their effect on HIV infection, with or without IL-6. To achieve specific aim 2, intracellular staining will be used to determine whether there is correlation between expression of BL-3, BCL-6 and phosphorylated SAMHD1 and HIV infection rates in EC stimulated resting CD4+ t cells. To achieve specific aim 3, intracellular staining for lineage-determining molecules will be used to identify potential subtypes of CD4+ t cells that have higher HIV infection rates upon EC stimulation. Single cell rnaseq method will also be used to identify novel subtypes and signature molecules that correlate with HIV infection in EC-stimulated resting t cells. The long-term objective of the study is to understand how endothelial cells impact HIV infection and latency formation in t helper cells. The knowledge gained from this study will significantly improve the understanding of HIV latent reservoir formation in a physiological context and will influence the strategies for battling viral persistence.
Quick answers
Who received award R15AI195005?
R15AI195005 was awarded to Calvin University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2026.
How much is award R15AI195005 worth?
$450,764 has been obligated on R15AI195005.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award